All
Results: 3049-3060 of 84627

Sun Mountain Partners, a Shareholder of Ashtead Technology, Urges the Board to Reject Ember’s 615p Proposal

EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis








